RE:RE:RE:RE:RE:RE:RE:Global company's DDHey all Fellow Kane holders;
I think Champ's intuition or tacit knowledge is right. The Big Pharma deal for DD is pretty much done. Whoopee...we may end up with marketing for animal wound cleaning and StrixNB.
I couldn't care really...except for the segue value of such a deal.
Just proving that the pipeline is worth looking at ...through cats that bite, dogs with bad breath and for the elimination of bacteria laden scum in animals is only one small step.
Kane's management does things slowly and methodically, which for us anxious holders can be frustrating, but they haven't lied or misled us once, which is very encouraging and appreciated to this holder of many juniors that have lied to me and disappointed many others.
Dispersin B and all the positive tests for potential human applications is what makes me hang on to my shares. The science is there. Read about it by simply googling and do your own DD, but the discovery which is a Kane trademark works.
I'm looking forward to hearing more on June 4th.
Curly